NCT03426150View on ClinicalTrials.gov

Casein Phosphopeptide--amorphous Calcium Phosphate on Human Enamel Subjected to in Vivo Acid Attacks

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 25, 2015

Primary Completion Date

October 25, 2017

Study Completion Date

February 5, 2018

Conditions
Dental Erosion
Interventions
DRUG

CPP-ACP

The surfaces of specimens were pretreated with CPP-ACP for 3 min

DRUG

Placebos

The surfaces of specimens were pretreated with deionized water for 3 min

All Listed Sponsors
lead

Fujian Medical University

OTHER

NCT03426150 - Casein Phosphopeptide--amorphous Calcium Phosphate on Human Enamel Subjected to in Vivo Acid Attacks | Biotech Hunter | Biotech Hunter